Tech Company Financing Transactions

Oryon Cell Therapies Funding Round

Oryon Cell Therapies, based in Redwood City, secured $21 million from Byers Capital and private investors.

Transaction Overview

Announced On
3/23/2026
Transaction Type
Venture Equity
Amount
$21,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to support completion of an ongoing Phase 1b/2a clinical trial of its lead neuron replacement therapy program, as well as the manufacturing scale-up and regulatory engagement needed to advance to a Phase 3 trial.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
303 Twin Dolphin Drive 600 � #1320
Redwood City, CA 94065
USA
Phone
Undisclosed
Email Address
Overview
Oryon Cell Therapies is a clinical-stage biotechnology company focused on developing autologous neuron replacement medicines for Parkinson's disease and other neurodegenerative disorders. Oryon is advancing a neuron replacement technology designed to restore neural circuitry. Unlike symptomatic therapies, this therapeutic approach is intended to produce durable biological restoration in neurodegenerative disorders, in which neuronal loss is well defined and directly linked to clinical impairment. The company's initial program is in Parkinson's disease.
Profile
Oryon Cell Therapies LinkedIn Company Profile
Social Media
Oryon Cell Therapies Company Twitter Account
Company News
Oryon Cell Therapies News
Facebook
Oryon Cell Therapies on Facebook
YouTube
Oryon Cell Therapies on YouTube

Management Team

Title
Name
Email & Social
Chairman
Emmett Cunningham
  Emmett Cunningham LinkedIn Profile  Emmett Cunningham Twitter Account  Emmett Cunningham News  Emmett Cunningham on Facebook
Chief Executive Officer
Ron Cohen
  Ron Cohen LinkedIn Profile  Ron Cohen Twitter Account  Ron Cohen News  Ron Cohen on Facebook
Co-Founder
Ole Isacson
  Ole Isacson LinkedIn Profile  Ole Isacson Twitter Account  Ole Isacson News  Ole Isacson on Facebook
Co-Founder
Nikola Kojic
  Nikola Kojic LinkedIn Profile  Nikola Kojic Twitter Account  Nikola Kojic News  Nikola Kojic on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/23/2026: Grub Lab venture capital transaction
Next: 3/23/2026: Zipline venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC investment data records on this site are derived from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary